by adminmps | Apr 29, 2022 | Uncategorized
MPS I Orchard Therapeutics Announces Interim Data for OTL-203 Showing Positive Clinical Results in Multiple Disease Manifestations of Mucopolysaccharidosis Type I Hurler Syndrome (MPS-IH). Read the full report >> SiglionTherapeutics, Development of a Novel...
by adminmps | Mar 29, 2022 | Uncategorized
This will be held on the evening of Saturday, July 22, 2023 in conjunction with the National Family Conference. Head to our National Family Conference page for more details!
by adminmps | Jan 13, 2022 | Uncategorized
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
